Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus rhamnosus GR-1 and Reduced Inflammation

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all 3 reported beneficial moderate-sized effects of Lactobacillus rhamnosus GR-1 on reducing inflammation, with 2 of 3 findings reaching statistical significance. Evidence is derived from in vitro human cell line models, bovine cell studies, and a mouse model; no human clinical trials are included. Dose and form were not reported in any study.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All studies are preclinical (cell lines or animal models), so direct applicability to humans is uncertain. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). No dose or form data were reported, limiting practical guidance.

Generated May 12, 2026
4 of 4 papers
Back to top